The executive team at GlycoMimetics has a history of experience in finance and accounting, as well as management positions in the healthcare industry. This includes working with small and emerging companies at the U.S. Securities and Exchange Commission, as well as experience in commercial operations and launching new products globally. The team is also educated, with degrees in accounting, general management, and healthcare from Shenandoah University, Cornell Johnson Graduate School of Management, and Queen's University respectively.
View all